AP-1 transcription factor

History

AP-1 was first discovered as a TPA-activated transcription factor that bound to a cis-regulatory element of the human metallothionein IIa (hMTIIa) promoter and SV40. The AP-1 binding site was identified as the 12-O-Tetradecanoylphorbol-13-acetate (TPA) response element (TRE) with the consensus sequence 5’-TGA G/C TCA-3’. The AP-1 subunit Jun was identified as a novel oncoprotein of avian sarcoma virus, and Fos-associated p39 protein was identified as the transcript of the cellular Jun gene. Fos was first isolated as the cellular homologue of two viral v-fos oncogenes, both of which induce osteosarcoma in mice and rats. Since its discovery, AP-1 has been found to be associated with numerous regulatory and physiological processes, and new relationships are still being investigated.

Structure

AP-1 transcription factor is assembled through the dimerization of a characteristic bZIP domain (basic region leucine zipper) in the Fos and Jun subunits. A typical bZIP domain consists of a “leucine zipper” region, and a “basic region”. The leucine zipper is responsible for dimerization of the Jun and Fos protein subunits. This structural motif twists two alpha helical protein domains into a “coiled coil,” characterized by a periodicity of 3.5 residues per turn and repetitive leucines appearing at every seventh position of the polypeptide chain. Due to the amino acid sequence and the periodicity of the helices, the leucine side chains are arranged along one face of the α helix and form a hydrophobic surface that modulates dimerization. Hydrophobic residues additional to leucine also form the characteristic 3-4 repeat of α helices involved in “coiled-coil” interactions, and help contribute to the hydrophobic packing that drives dimerization. Together, this hydrophobic surface holds the two subunits together.

The basic region of the bZIP domain is just upstream to the leucine zipper, and contains positively charged residues. This region interacts with DNA target sites. Apart from the “leucine zipper” and the “basic region” which are important for dimerization and DNA-binding, the c-jun protein contains three short regions, which consist of clusters of negatively charged amino acids in its N-terminal half that are important for transcriptional activation in vivo.

Dimerization happens between the products of the c-jun and c-fos protooncogenes, and is required for DNA-binding. Jun proteins can form both homo and heterodimers and therefore are capable of binding to DNA by themselves. However, Fos proteins do not dimerize with each other and therefore can only bind to DNA when bound with Jun. The Jun-Fos heterodimer is more stable and has higher DNA-binding activity than Jun homodimers.

Function

AP-1 transcription factor has been shown to have a hand in a wide range of cellular processes, including cell growth, differentiation, and apoptosis. AP-1 activity is often regulated via post-translational modifications, DNA binding dimer composition, and interaction with various binding partners. AP-1 transcription factors are also associated with numerous physiological functions especially in determination of organisms’ life span and tissue regeneration. Below are some of the other important functions and biological roles AP-1 transcription factors have been shown to be involved in.

Cell growth, proliferation and senescence

The AP-1 transcription factor has been shown to play numerous roles in cell growth and proliferation. In particular, c-Fos and c-Jun seem to be major players in these processes. C-jun has been shown to be essential for fibroblast proliferation, and levels of both AP-1 subunits have been shown to be expressed above basal levels during cell division. C-fos has also been shown to increase in expression in response to the introduction of growth factors in the cell, further supporting its suggested involvement in the cell cycle. The growth factors TGF alpha, TGF beta, and IL2 have all been shown to stimulate c-Fos, and thereby stimulate cellular proliferation via AP-1 activation.

Cellular senescence has been identified as "a dynamic and reversible process regulated by (in)activation of a predetermined enhancer landscape controlled by the pioneer transcription factor AP-1", which "defines the organizational principles of the transcription factor network that drives the transcriptional programme of senescent cells".

Cellular differentiation

AP-1 transcription is deeply involved in the modulation of gene expression. Changes in cellular gene expression in the initiation of DNA synthesis and the formation of differentiated derivatives can lead to cellular differentiation. AP-1 has been shown to be involved in cell differentiation in several systems. For example, by forming stable heterodimers with c-Jun, the bZIP region of c-Fos increases the binding of c-Jun to target genes whose activation is involved in the differentiation of chicken embryo fibroblasts (CEF). It has also been shown to participate in endoderm specification.

Apoptosis

AP-1 transcription factor is associated with a broad range of apoptosis related interactions. AP-1 activity is induced by numerous extracellular matrix and genotoxic agents, suggesting involvement in programmed cell death. Many of these stimuli activate the c-Jun N-terminal kinases (JNKs) leading to the phosphorylation of Jun proteins and enhanced transcriptional activity of AP-1 dependent genes. Increases in the levels of Jun and Fos proteins and JNK activity have been reported in scenarios in which cells undergo apoptosis. For example, inactivated c-Jun-ER cells show a normal morphology, while c-Jun-ER activated cells have been shown to be apoptotic.

Tissue-specific regulation

It has been shown that AP-1 motif regulates tissue-specific genes through enhancer selection mechanism in fibroblasts. It has been shown that AP-1 motif is related to epigenetic regulation in kidney function and now there is suspect that AP-1 motif is regulated in developing RPE, specifically through OTX2.

Regulation of AP-1

Increased AP-1 levels lead to increased transactivation of target gene expression. Regulation of AP-1 activity is therefore critical for cell function and occurs through specific interactions controlled by dimer-composition, transcriptional and post-translational events, and interaction with accessory proteins.

AP-1 functions are heavily dependent on the specific Fos and Jun subunits contributing to AP-1 dimers. The outcome of AP-1 activation is dependent on the complex combinatorial patterns of AP-1 component dimers. The AP-1 complex binds to a palindromic DNA motif (5’-TGA G/C TCA-3’) to regulate gene expression, but specificity is dependent on the dimer composition of the bZIP subunit.

Physiological relevance

AP-1 transcription factor has been shown to be involved in skin physiology, specifically in tissue regeneration. The process of skin metabolism is initiated by signals that trigger undifferentiated proliferative cells to undergo cell differentiation. Therefore, activity of AP-1 subunits in response to extracellular signals may be modified under conditions where the balance of keratinocyte proliferation and differentiation has to be rapidly and temporally altered. The AP-1 transcription factor also has been shown to be involved in breast cancer cell growth through multiple mechanisms, including regulation of cyclin D1, E2F factors and their target genes. c-Jun, which is one of the AP-1 subunits, regulates the growth of breast cancer cells. Activated c-Jun is predominantly expressed at the invasive front in breast cancer and is associated with proliferation of breast cells. Due to the AP-1 regulatory functions in cancer cells, AP-1 modulation is studied as a potential strategy for cancer prevention and therapy.

Regulome

References

References

1. (December 2004). "AP-1 subunits: quarrel and harmony among siblings". Journal of Cell Science.
2. (August 2003). "A role for AP-1 in apoptosis: the case for and against". Biochimie.
3. (January 1987). "Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40". Nature.
4. (June 1987). "Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor". Cell.
5. (April 2001). "AP-1--Introductory remarks". Oncogene.
6. (June 1988). "The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins". Science.
7. (1990). "jun: oncogene and transcription factor". Advances in Cancer Research.
8. (December 1991). "The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.
9. (December 1988). "The role of the leucine zipper in the fos-jun interaction". Nature.
10. (December 1988). "DNA binding activities of three murine Jun proteins: stimulation by Fos". Cell.
11. (April 1997). "AP-1 function and regulation". Current Opinion in Cell Biology.
12. (2006). "The Activating Protein-1 Transcriptional Complex: Essential and Multifaceted Roles in Bone". Clinical Reviews in Bone and Mineral Metabolism.
13. (2020). "In and out from senescence". Nat Cell Biol.
14. (2020). "AP-1 imprints a reversible transcriptional programme of senescent cells". Nat Cell Biol.
15. (May 2002). "AP-1 as a regulator of cell life and death". Nature Cell Biology.
16. (January 25, 2023). "Epigenetic and transcriptional regulations prime cell fate before division during human pluripotent stem cell differentiation". Nature Communications.
17. (April 1997). "Induction of apoptosis by the transcription factor c-Jun". The EMBO Journal.
18. (December 2017). "AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection". Mol Cell.
19. (February 2024). "Kidney-specific methylation patterns correlate with kidney function and are lost upon kidney disease progression". Clin Epigenetics.
20. (July 2009). "Translational regulation mechanisms of AP-1 proteins". Mutation Research.
21. (April 2001). "Function and regulation of AP-1 subunits in skin physiology and pathology". Oncogene.
22. (January 2008). "The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors". Oncogene.
23. (November 2003). "AP-1: a double-edged sword in tumorigenesis". Nature Reviews. Cancer.
24. (February 2018). "Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention". Pharmacological Research.
25. (May 2016). "Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model". Cancer Science.
26. (January 1995). "An ATF/CREB-binding site is essential for cell-specific and inducible transcription of the murine MIP-1 beta cytokine gene". Gene.
27. (February 2002). "Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase". Journal of Immunology.
28. (April 2002). "AP-1 functions upstream of CREB to control synaptic plasticity in Drosophila". Nature.
29. (July 2005). "Common pathways in circadian and cell cycle clocks: light-dependent activation of Fos/AP-1 in zebrafish controls CRY-1a and WEE-1". Proceedings of the National Academy of Sciences of the United States of America.
30. (July 2006). "Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells". The Journal of Biological Chemistry.
31. (May 1994). "Induction of the rat prodynorphin gene through Gs-coupled receptors may involve phosphorylation-dependent derepression and activation". Molecular and Cellular Biology.
32. (December 2005). "Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway". Cancer Research.
33. (August 2001). "Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes". Molecular Biology of the Cell.
34. (November 2000). "c-Jun (AP-1) activates BMP-4 transcription in Xenopus embryos". Mechanisms of Development.
35. (December 2004). "Global expression analysis of ECL cells in Mastomys natalensis gastric mucosa identifies alterations in the AP-1 pathway induced by gastrin-mediated transformation". Physiological Genomics.
36. (January 1992). "Comparison of a cloned ANF-sensitive guanylate cyclase (GC-A) with particulate guanylate cyclase from adrenal cortex". Naunyn-Schmiedeberg's Archives of Pharmacology.
37. (April 2007). "Flashlamp pulsed-dye laser suppressed TGF-beta1 expression and proliferation in cultured keloid fibroblasts is mediated by MAPK pathway". Lasers in Surgery and Medicine.
38. (March 2007). "Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation". Molecular and Cellular Biology.
39. (2008). "Regulation and functions of Blimp-1 in T and B lymphocytes". Annual Review of Immunology.
40. (2003). "Redox-regulation of DNA repair". BioFactors.
41. (June 2006). "Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL". Journal of Immunology.
42. (September 1999). "Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells". Arteriosclerosis, Thrombosis, and Vascular Biology.
43. (May 2008). "miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism". Journal of Molecular Biology.
44. (February 1999). "NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages". Molecular Biology of the Cell.
45. (October 2006). "Fab1p and AP-1 are required for trafficking of endogenously ubiquitylated cargoes to the vacuole lumen in S. cerevisiae". Journal of Cell Science.
46. (December 2005). "Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers". Blood.
47. (May 2004). "HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells". Molecular Cancer Research.
48. (April 2002). "Effect of human milk and epidermal growth factor on growth of human intestinal Caco-2 cells". Journal of Pediatric Gastroenterology and Nutrition.
49. (July 1998). "The activity of a highly promiscuous AP-1 element can be confined to neurons by a tissue-selective repressive element". The Journal of Neuroscience.
50. (June 1987). "Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements". Cell.
51. (May 1999). "Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells". The American Journal of Physiology.
52. (April 2005). "Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies". Virology Journal.
53. (December 1998). "Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes". The Journal of Clinical Investigation.
54. (March 2007). "Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system". Carcinogenesis.
55. (June 2001). "Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells". Diabetologia.
56. (November 2001). "Photoaging: pathogenesis, prevention, and treatment". Clinics in Geriatric Medicine.
57. (June 1998). "Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines". Journal of Lipid Research.
58. (2007). "Retinoic acid inhibits serum-stimulated activator protein-1 ''via'' suppression of ''c-fos'' and ''c-jun'' gene expressions during the vitamin-induced differentiation of mouse osteoblastic cell line MC3T3-E1 cells". J. Meikai Dent. Med..
59. (November 2002). "Transcriptional regulation of a mesangium-predominant gene, megsin". Journal of the American Society of Nephrology.
60. (April 1999). "Human cytomegalovirus IE1 protein activates AP-1 through a cellular protein kinase(s)". The Journal of General Virology.
61. (November 2004). "The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells". Journal of Immunology.
62. (November 1999). "RIP2 is a Raf1-activated mitogen-activated protein kinase kinase". The Journal of Biological Chemistry.
63. (August 1995). "Neurotransporters: regulation, involvement in neurotoxicity, and the usefulness of antisense nucleic acids". Biochemical Pharmacology.
64. (February 2001). "A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation". Oncogene.
65. (December 2005). "Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways". Journal of Virology.
66. (April 2008). "Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium". Infection and Immunity.
67. (January 2007). "Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2". Infection and Immunity.
68. (December 2004). "Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells". Molecular Endocrinology.
69. (September 2003). "Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein". Journal of Virology.
70. (June 2002). "Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies". Clinical Cancer Research.
71. (May 1996). "Antioxidant PDTC induces stromelysin expression in mesangial cells via a tyrosine kinase-AP-1 pathway". The American Journal of Physiology.
72. (April 2014). "(-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways". Annals of Clinical and Translational Neurology.
73. (February 2008). "Macrophage migration inhibitory factor has a MHC class I-like motif and function". Scandinavian Journal of Immunology.
74. [https://www.uniprot.org/uniprot/P05412 Uniprot Database]
75. (Feb 2020). "The antiaging activity of ergothioneine in UVA-irradiated human dermal fibroblasts via the inhibition of the AP-1 pathway and the activation of Nrf2-mediated antioxidant genes". Oxid Med Cell Longev.
76. (2016). "Gene regulation in the immediate-early response process". Advances in Biological Regulation.